Scientific models project a continued decrease in lung cancer mortality.
Non-cigarette tobacco use has increased by over 100% in the last 2 decades.
Data indicate that beta-Carotene should not be recommended as a cancer prevention agent due to lack of efficacy and potential harm among smokers or those exposed to asbestos.
NCCN guidelines recommend that smoking cessation be provided as part of oncology treatment.
Requirements for Medicare coverage of CT lung cancer screening might be a factor for low screening rates among high-risk smokers.
Smoking cessation may improve survival regardless of the type of cancer diagnosed, due to a reduction in comorbidities.
Tobacco Companies Seeking To Influence Policy Are Violating the Framework Convention on Tobacco ControlDecember 07, 2016
Tobacco industry representatives are continuing to meet with and are attempting to influence government officials in many countries.
Although rates of smoking in the U.S. have declined to new lows, health officials still estimate that four out of every 10 cancers is linked to the habit.
Women who continue to smoke after being diagnosed with breast cancer are almost twice as likely as those who never smoked to die of their disease.
Advanced periodontitis may be associated with a 2.5-fold increased risk of smoking-related cancers among patients who never smoke.
Despite reports to the FDA regarding adverse events of e-cigarettes and concerns from health organizations, sales continue without regulatory oversight.
Three-quarters of American adults favor raising the legal smoking age to 21.
For patients with head and neck cancer, smoking and alcohol consumption predict gastrostomy tube (GT) insertion use.
58 million nonsmokers are still being exposed to secondhand smoke.
Smoking increases risks for side effects and recurrence in patients being treated for prostate cancer.
Tobacco increases risk for developing head and neck cancer, but the effect on postoperative outcomes is unknown.
People who smoke hookah had a signficiantly increased amount of benzene and leukemia risk.
Active smokers more knowledgeable of bladder cancer risk than former, never smokers; often cite urologist as source of info.
Highest prevalence of smoking found among survivors of bladder, lung, and ovarian cancer.
A subsidiary of Reynolds American is announcing that it will begin distributing its Vuse e-cigarettes across the United States on June 23.
An automated, personalized, and interactive mobile health program, Text2Quit, seems to be effective for promoting smoking cessation.
Recommendations include a rule on minimum age age for purchasing and flavor restrictions.
Most U.S. adults are aware of electronic cigarettes and about half believe they are less harmful than cigarettes
Report shows many women are unaware of incidence, poor survival rates, and risk of lung cancer for nonsmokers.
The portrayal of tobacco use on TV dramas has decreased since 1955, in line with historical cigarette consumption trends.
A study from the NIH/AARP show that mortality from colorectal cancers is affected by lifestyle factors such as smoking, alcohol consumption, and obesity.
Teens who have tried electronic cigarettes may be more likely to smoke regular cigarettes, according to a new study.
Smoking exposure adversely impacts cancer-specific survival and increases the risk of death from another cause in patients with renal cell carcinoma.
Younger women who smoke appear to be at increased risk for developing estrogen receptor (ER)-positive breast cancer.
The national drug store chain CVS Caremark said Wednesday that it's phasing out the sale of tobacco products.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- CAR-T Trial for Triple-Negative Breast Cancer Under Way
- Daratumumab Combination: New Standard of Care in Transplant-Ineligible Multiple Myeloma
- Adjuvant Trastuzumab Emtansine Confers Improved Outcome in KATHERINE Trial
- Phase 3 GEICAM/CIBOMA Results: Adjuvant Capecitabine in Triple-Negative Breast Cancer
- Extension of Adjuvant Anastrozole Regimen to 10 Years Yields Higher DFS, but Not OS
- Molecular Mechanisms Underlying Immunosurveillance in Multiple Myeloma Identified
- Gly101Val Mutation Directly Causes Resistance to Venetoclax
- Can Treatments for Childhood ALL Alter the Gut Microbiome?
- Olaratumab May Be Safe and Effective in Patients With Advanced Soft Tissue Sarcoma
- Next-Generation Sequencing May Benefit Some Patients With Sarcoma